Skip to main content

A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Orally administered PLX3397 in Subjects with Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Daiichi Pharmaceutical Corporation

Start Date

August 1, 2015

End Date

July 31, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Daiichi Pharmaceutical Corporation

Start Date

August 1, 2015

End Date

July 31, 2021